2023
DOI: 10.1016/j.jadr.2022.100461
|View full text |Cite
|
Sign up to set email alerts
|

Development and implementation of mindfulness-based psychological intervention program on premenstrual dysphoric symptoms and quality of life among late adolescents: A pilot study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 22 publications
0
1
0
Order By: Relevance
“…This is consistent with a survey of 385 medical students, where an increase in PMS symptoms such as emotional disturbance, weakness, mastalgia and sleep disturbance during the pandemic was observed [ 31 ]. In addition, a study of 400 college students identified a 19% increase in the prevalence of premenstrual dysphoric disorder and 43.3% uptake of premenstrual syndrome amongst the cohort during the pandemic [ 34 ]. This is perhaps unsurprising, given that PMS symptoms are often related to stressful events [ 35 , 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…This is consistent with a survey of 385 medical students, where an increase in PMS symptoms such as emotional disturbance, weakness, mastalgia and sleep disturbance during the pandemic was observed [ 31 ]. In addition, a study of 400 college students identified a 19% increase in the prevalence of premenstrual dysphoric disorder and 43.3% uptake of premenstrual syndrome amongst the cohort during the pandemic [ 34 ]. This is perhaps unsurprising, given that PMS symptoms are often related to stressful events [ 35 , 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…remenstrual dysphoric disorder (PMDD) encompasses a cyclic occurrence of physical, cognitive, emotional, and behavioral symptoms during the luteal phase of the menstrual cycle that subside with the onset of menstruation or shortly thereafter (Puthusserry & Delariarte, 2023). Studies have shown that while 75% of women in their reproductive years are affected by premenstrual symptoms (Kulkarni et al, 2022), between 5 to 8% suffer from severe forms of the disorder, impacting 3 to 8% of women per menstrual cycle (Acikgoz et al, 2017;Erbil & Yücesoy, 2023).…”
Section: Introductionmentioning
confidence: 99%
“…A range of biopsychomedical interventions such as antidepressants, anti-anxiety medications, and hormonal treatments are employed (Sharma et al, 2022); although these may reduce premenstrual symptoms, none address the complex underlying mechanisms of premenstrual distress and discomfort (Kulkarni et al, 2022). Consequently, psychological and non-pharmacological treatments have been developed to improve and alleviate the symptoms of premenstrual disorders, including metacognitive therapy (Puthusserry & Delariarte, 2023). This model suggests that negative thoughts and feelings are transient; however, when an individual responds to them with cognitive attention syndrome, it may lead to prolonged psychological distress and unintentionally exacerbate negative affect (Batmaz & Altınöz, 2023).…”
Section: Introductionmentioning
confidence: 99%